Document Detail


Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene: a distinct clinical, pathological and genetic entity with potential treatment target?
MedLine Citation:
PMID:  22288769     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Monika Prochorec-Sobieszek; Barbara Nasiłowska-Adamska; Katarzyna Borg; Izabella Kopeć; Kinga Kos-Zakrzewska; Przemysław Juszczyński; Krzysztof Warzocha
Related Documents :
9439979 - Effects of interferon-alpha therapy on lymphocyte subpopulations in patients with chron...
1909399 - Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with hi...
3479189 - Flow cytochemical patterns of white blood cells in human haematopoietic malignancies. i...
17910629 - Risk factors for development of a second lymphoid malignancy in patients with chronic l...
391039 - Clinical usefulness and reproducibility of histologic subclassification of advanced dif...
10494449 - Immunological alterations in adult obsessive-compulsive disorder.
3609849 - Vasopressin response to lactate infusion in normals and patients with panic disorder.
23037129 - Distinct clinical features of two patients that progressed from the early phase of chro...
22302059 - The provisional acr/eular definition of remission in ra: a comment on the patient globa...
Publication Detail:
Type:  Case Reports; Letter     Date:  2012-03-13
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  53     ISSN:  1029-2403     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-08-09     Completed Date:  2013-01-04     Revised Date:  2013-03-26    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  England    
Other Details:
Languages:  eng     Pagination:  1824-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / therapeutic use
Cell Proliferation
Chromosomes, Human, Pair 8 / genetics
Chromosomes, Human, Pair 9 / genetics
Chronic Disease
Diagnosis, Differential
Erythroblasts / pathology*
Female
Humans
Hydroxyurea / therapeutic use
Hypereosinophilic Syndrome / diagnosis*,  drug therapy
Infant, Newborn
Interferon-alpha / therapeutic use
Oncogene Proteins, Fusion / genetics*
Pregnancy
Pregnancy Complications, Hematologic / diagnosis,  drug therapy,  genetics
Pregnancy Complications, Neoplastic / diagnosis,  drug therapy,  genetics
Translocation, Genetic*
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Interferon-alpha; 0/Oncogene Proteins, Fusion; 0/PCM1-JAK2 fusion protein, human; 127-07-1/Hydroxyurea

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Local administration of insulin-like growth factor-I (IGF-I) stimulates tendon collagen synthesis in...
Next Document:  Effect of local exposure to inhomogeneous static magnetic field on stomatological pain sensation - a...